Life sciences company focused on bringing psychedelic medicine to market through delivery of novel delivery systems Core One Labs Inc. (CSE: COOL) (OTCMKTS: CLABF) announced having completed the acquisition of Frontier Mycology Corp. for CAD 7.5 million.
Frontier Mycology is a compilation of world’s top mushroom news it provides compelling content such as media coverage, financial analysis, news and relevant research on both psychedelic and functional mushrooms.
On its website, Frontier Mycolofy states that its main objective is to reduce the stigma towards psychedelic medicines trough providing transparency and information related to all aspects of the psychedelic sector.
“This acquisition further expands our presence in the psychedelic space, by allowing us access to potential investors who utilize this website as a tool for keeping up to date on this growing industry. The direct to consumer e-commerce platform for functional mushrooms, also allows the company to generate sales to consumers, who can then be converted to different products as the legalization of psychedelics progresses,” said the CEO of Core One Labs, Joel Shacker.
